Collaborative Stage

Note 1: In the case of multiple simultaneous tumors, code the tumor with greatest extension.
Note 2: Skin ulceration does not alter the AJCC T category.
Note 3: Presence of tumor at eyelid margin takes priority over depth of invasion in dermis/tarsal plate; i.e., code 250 takes priority over codes 100-200.
Note 4: Metastatic skin lesions are coded in CS Mets at DX.

^ For CS Extension codes 100-400 ONLY, the T category for AJCC 7 staging is assigned based on the value of CS Tumor Size, CS Extension, and Perineural Invasion recorded in CS Site-Specific Factor 6, as shown in the Extension Size, Perineural Invasion Negative or Unknown AJCC 7 Table, the Extension Size, Perineural Invasion Positive AJCC 7 Table, and the Extension Size, Perineural Invasion 888, 988 Table for this schema.
* For cases coded in CSv1 (CS Version Input Original equals 01XXXX) and Year of Diagnosis is less than 2010 and CS-Site Specific Factor 6, Perineural Invasion = 988 or blank, the T category for AJCC 6 staging is assigned based on the value of CS Tumor Size and CS Extension as shown in the Extension Size AJCC 6 Table CSv1 for this schema.
For cases coded in CSv2 and cases coded in CSv1 with Year of Diagnosis less than 2010 and Perineural Invasion not coded to 988 or blank, using CS Extension codes 100-400 ONLY, the T category for AJCC 6 staging is assigned based on the value of CS Tumor Size, CS Extension, and Perineural Invasion recorded in CS Site-Specific Factor 6, as shown in the Extension Size, Perineural Invasion Negative or Unknown AJCC 6 Table CSv2, the Extension Size, Perineural Invasion Positive AJCC 6 Table CSv2, and the Extension Size, Perineural Invasion 888, 988 Table CSv2 for this schema.

Code	Description	TNM 7 Map	TNM 6 Map	SS77 Map	SS2000 Map
000	In situ, intraepidermal, intraepithelial, noninvasive Bowen disease	Tis	Tis	IS	IS
100	Lesion(s) confined to dermis Minimal infiltration of dermis (Not invading tarsal plate, not at eyelid margin)	^	*	L	L
150	Subcutaneous tissue (Through entire dermis, not invading tarsal plate, not at eyelid margin)	^	*	L	L
155	Stated as T1 with no other information on extension	^	*	L	L
200	Tumor invades tarsal plate, not at eyelid margin	^	*	L	L
250	Tumor at eyelid margin	^	*	L	L
270	Stated as T2a with no other information on extension	^	*	L	L
300	Tumor involves full eyelid thickness	^	*	L	L
320	Stated as T2b with no other information on extension	^	*	L	L
340	Stated as T2 [NOS] with no other information on extension	^	*	L	L
400	Localized, NOS	^	*	L	L
500	OBSOLETE DATA CONVERTED V0200 See code 150 Subcutaneous tissue (through entire dermis)	ERROR	ERROR	ERROR	ERROR
600	OBSOLETE DATA RETAINED V0200 See code 610, CS SSF 3 for perineural space involvement Adjacent structures, including: Bulbar conjunctiva Globe Perineural space Sclera Soft tissues of orbit	ERROR	T4	D	RE
610	Adjacent structures, including: Bulbar conjunctiva Globe Sclera Soft tissues of orbit	T3a	T4	D	RE
620	Bone/periosteum of orbit Skeletal muscle Underlying cartilage	T3a	T4	D	RE
650	Stated as T3a with no other information on extension	T3a	T3	D	RE
670	Complete resection requires enucleation, exenteration, or bone resection Stated as T3b with no other information on extension	T3b	T4	D	RE
690	Stated as T3 [NOS] with no other information on extension	T3NOS	T4	D	RE
700	OBSOLETE DATA CONVERTED V0200 See code 620 Bone/periosteum of orbit Skeletal muscle Underlying cartilage	ERROR	ERROR	ERROR	ERROR
715	Tumor unresectable, extensive invasion: Ocular structures Orbital structures	T4	T4	D	RE
720	Nasal cavity Paranasal sinuses Other craniofacial structures	T4	T4	D	D
740	Central nervous system	T4	T4	D	D
750	OBSOLETE DATA CONVERTED V0200 See CS Extension Code 999 and CS Mets at DX Codes 20, 30, 55, 58 Metastatic skin lesion(s)	ERROR	ERROR	ERROR	ERROR
800	Further contiguous extension	T4	T4	D	D
810	Stated as T4 with no other information on extension	T4	T4	D	D
950	No evidence of primary tumor	T0	T0	U	U
999	Unknown; extension not stated Primary tumor cannot be assessed Not documented in patient record	TX	TX	U	U

SkinEyelid

CS Extension